The Differential Diagnostic Value of Chest Computed Tomography for the Identification of Pathogens Causing Pulmonary Infections in Patients with Hematological Malignancies
Qian Cheng,Yishu Tang,Jing Liu,FeiYang Liu,Xin Li
DOI: https://doi.org/10.2147/idr.s474229
2024-10-22
Infection and Drug Resistance
Abstract:Qian Cheng, 1 Yishu Tang, 2 Jing Liu, 1 FeiYang Liu, 1, &ast Xin Li 1, &ast 1 Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; 2 Department of Emergency, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China &astThese authors contributed equally to this work Correspondence: FeiYang Liu; Xin Li, Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, People's Republic of China, Tel +86-731-88618814 (88618214) ; Tel +86-731-88618814 (88618214), Email ; Objective: The role of chest computed tomography (CT) in distinguishing the causative pathogens of pulmonary infections in patients with hematological malignancies (HM) is unclear. The aim of our study was to compare and assess the clinical characteristics, radiologic features and potential differential diagnostic value of CT in HM patients and other different immune statuses patients with pulmonary infections. Methods: Patients were divided into immunocompetent (105 cases) and immunocompromised groups (99 cases) according to immune status. Immunocompromised patients included the HM group (63 cases) and the non-HM group (42 cases). The basic clinical data and CT findings were collected and statistically analyzed. Results: Regarding the pathogen distribution, viral, Pneumocystis jirovecii and mixed infections were more common in the immunocompromised group than the immunocompetent (p < 0.01), but viral infections were more common in the HM group than in the non-HM group (p=0.013). Immunocompromised patients had more diverse CT findings and more serious lesions (mostly graded 2– 4) than immunocompetent patients. The most common CT findings in HM patients were consolidation and ground-glass opacities (GGO), which were also found in the non-HM group. The overall diagnostic accuracy of CT was lower in immunocompromised patients than in immunocompetent patients (25.7% vs 50.5%, p< 0.01). CT had better diagnostic efficacy for fungi and Pneumocystis jirovecii in HM patients. Conclusion: CT diagnosis is less efficient in distinguishing the causative pathogens of HM patients. However, CT can help distinguish fungal pneumonia and Pneumocystis jirovecii pneumonia in HM patients. Clinical Relevance Statement: Our study might facilitate clinical decision-making in fungal pneumonia and Pneumocystis jirovecii pneumonia in HM patients. Keywords: pneumonia, hematological malignancies, computed tomography, diagnostic value Patients diagnosed with hematological malignancies (HM) are usually susceptible to infections due to considerable immunosuppression mainly caused by chemotherapies. 1 It has been reported that approximately 17–50% of HM patients develop pulmonary infections during their treatment. 2,3 Severe and complicated pulmonary infections might increase overall mortality. 4 A prompt and accurate pathogenic diagnosis of pulmonary infections facilitates optimal antimicrobial therapy and thus decreases infection-related mortality. 5 Conventional microbiological tests such as blood culture, sputum culture, and other novel detection methods, including next-generation sequencing (NGS), have been extensively used for the diagnosis of pulmonary infections. However, these conventional tests have limitations in many aspects, such as long detection cycles, low sensitivity, and high costs. 6 Few studies have evaluated the use of noninvasive, rapid diagnostic tests to identify pathogens in HM patients with pulmonary infections. Imaging plays a crucial role in the detection and management of patients with pneumonia. 7 Chest radiography has limited sensitivity and shows normal results in up to 10% of patients with pulmonary diseases. 8,9 Early chest computed tomography (CT) can be used to detect lesions missed by conventional chest radiography, which is used to identify pulmonary infections in immunocompetent patients. 10 However, patients with a compromised immune system suffer from a wide range of lung diseases and have diverse imaging features. 11 For instance, among patients affected by nontuberculous mycobacterial infection, large opacities and cavitation in pulmonary nodules are more frequent in immunocompromised than in immunocompetent patients. 12 Therefore, distinguishing different pathogens is often difficult due to nonspecific chest symptoms and radiologic findings in immunocompromised patients. 13 Some reports revealed that the differential dia -Abstract Truncated-
pharmacology & pharmacy,infectious diseases